Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

By Kasimir-Bauer S.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 123-132

Springer Publishing Company

Access to resources Recommend Favorite

The Detection of Micrometastases in the Peripheral Blood and Bone Marrow of Patients with Breast Cancer Using Immunohistochemistry and Reverse Transcriptase Polymerase Chain Reaction for Keratin 19

By Schoenfeld A.   Kruger K.H.   Gomm J.   Sinnett H.D.   Gazet J.-C.   Sacks N.   Bender H.G.   Luqmani Y.   Coombes R.C.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 854-861

Elsevier

Access to resources Recommend Favorite

Bone marrow micrometastases in patients with stage I-II localised prostate cancer

By Vagunda V.   Landys K.   Kankkunen J.-P.   Vagundova M.   Hultborn R.   Kovarik J.   Hugosson J.  

European Journal of Cancer, Vol. 37, Iss. 15, 2001-10 ,pp. : 1847-1852

Elsevier

Access to resources Recommend Favorite

The Prognostic Impact of Bone Marrow Micrometastases in Women with Breast Cancer

By Braun Stephan   Auer Doris   Marth Christian  

Cancer Investigation, Vol. 27, Iss. 6, 2009-07 ,pp. : 598-603

Informa Healthcare

Access to resources Recommend Favorite

Relevance of Micrometastases and Targeting the Bone Marrow Niche with Zoledronic Acid in Breast Cancer

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 2, 2012-05 ,pp. : 152-160

Bentham Science Publishers

Access to resources Recommend Favorite